search
Back to results

RCT on Ketorolac and Tramadol in Bone Fractures Pain of Child

Primary Purpose

Fracture, Pain

Status
Completed
Phase
Phase 4
Locations
Italy
Study Type
Interventional
Intervention
ketorolac
tramadol
Sponsored by
IRCCS Burlo Garofolo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Fracture focused on measuring bone fracture, ketorolac, tramadol

Eligibility Criteria

4 Years - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Children 4-17 years old with not compound bone fracture presenting in emergency room

Exclusion Criteria:

  • Compound fracture
  • Occurring pain still treated
  • Contraindicated ketorolac or tramadol use
  • Informed consensus not obtained

Sites / Locations

  • IRCCS Burlo Garofolo

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

1

2

Arm Description

children 4-17 y. old with not compound bone fracture treated with ketorolac

children 4-17 y. old with not compound bone fracture treated with tramadol

Outcomes

Primary Outcome Measures

estimation of pain reduction in every arm of the trial with linear 1-10 pain scale or for children 4 - 6 years old with analogic MacGrath type scale

Secondary Outcome Measures

comparison between the two groups on effectiveness on pain, measured with linear and analogic scale (see above)

Full Information

First Posted
November 7, 2007
Last Updated
August 23, 2017
Sponsor
IRCCS Burlo Garofolo
search

1. Study Identification

Unique Protocol Identification Number
NCT00560443
Brief Title
RCT on Ketorolac and Tramadol in Bone Fractures Pain of Child
Official Title
Randomized Controlled Trial on Effectiveness of Ketorolac and Tramadol in Not Compound Fractures of Child
Study Type
Interventional

2. Study Status

Record Verification Date
August 2017
Overall Recruitment Status
Completed
Study Start Date
February 2008 (Actual)
Primary Completion Date
April 2012 (Actual)
Study Completion Date
April 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
IRCCS Burlo Garofolo

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Randomized double blind Trial with the aim to estimate effectiveness of two therapeutic regimes per os on pain due to not compound bone fractures in child 4-17 years old: ketorolac 0,5 mg/kg (1 drop every 2 Kg) tramadol 2,5 mg/Kh (1 drop every 2 Kg) Intensity of pain will be estimated with linear 1 to 10 or analogic McGrath type scale every 20 min. The main objectives are the evaluation of pain decreasing in every group, the time of decreasing, the intensity of pain during procedures (ex. Xray) and the occurrence of side effects Secondary outcomes are comparison between the two groups on effectiveness on pain and on side effects

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fracture, Pain
Keywords
bone fracture, ketorolac, tramadol

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
133 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Description
children 4-17 y. old with not compound bone fracture treated with ketorolac
Arm Title
2
Arm Type
Experimental
Arm Description
children 4-17 y. old with not compound bone fracture treated with tramadol
Intervention Type
Drug
Intervention Name(s)
ketorolac
Intervention Description
0,5 mg/kg per os one time
Intervention Type
Drug
Intervention Name(s)
tramadol
Intervention Description
2,5 mg/ kg per os in one dose
Primary Outcome Measure Information:
Title
estimation of pain reduction in every arm of the trial with linear 1-10 pain scale or for children 4 - 6 years old with analogic MacGrath type scale
Time Frame
6 hours (or until the end of procedures)
Secondary Outcome Measure Information:
Title
comparison between the two groups on effectiveness on pain, measured with linear and analogic scale (see above)
Time Frame
6 hours or until the end of procedures

10. Eligibility

Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Children 4-17 years old with not compound bone fracture presenting in emergency room Exclusion Criteria: Compound fracture Occurring pain still treated Contraindicated ketorolac or tramadol use Informed consensus not obtained
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Edoardo Guglia, md
Organizational Affiliation
IRCCS Burlo Garofolo
Official's Role
Principal Investigator
Facility Information:
Facility Name
IRCCS Burlo Garofolo
City
Trieste
ZIP/Postal Code
34100
Country
Italy

12. IPD Sharing Statement

Citations:
PubMed Identifier
23702435
Citation
Neri E, Maestro A, Minen F, Montico M, Ronfani L, Zanon D, Favret A, Messi G, Barbi E. Sublingual ketorolac versus sublingual tramadol for moderate to severe post-traumatic bone pain in children: a double-blind, randomised, controlled trial. Arch Dis Child. 2013 Sep;98(9):721-4. doi: 10.1136/archdischild-2012-303527. Epub 2013 May 23.
Results Reference
derived

Learn more about this trial

RCT on Ketorolac and Tramadol in Bone Fractures Pain of Child

We'll reach out to this number within 24 hrs